Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1534-90-3 | MDL No. : | MFCD02259530 |
Formula : | C11H15ClFNO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | KMTPBETYAVWMHD-PPHPATTJSA-N |
M.W : | 247.69 | Pubchem ID : | 56777149 |
Synonyms : |
|
Num. heavy atoms : | 16 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.36 |
Num. rotatable bonds : | 5 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 61.55 |
TPSA : | 52.32 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.41 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 1.98 |
Log Po/w (WLOGP) : | 2.48 |
Log Po/w (MLOGP) : | 2.38 |
Log Po/w (SILICOS-IT) : | 2.18 |
Consensus Log Po/w : | 1.8 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.57 |
Solubility : | 0.666 mg/ml ; 0.00269 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.7 |
Solubility : | 0.489 mg/ml ; 0.00197 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.26 |
Solubility : | 0.136 mg/ml ; 0.000551 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.16 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
98% | With hydrogenchloride In ethanol | Example 1 L-Melphalanyl-L-p-fluorophenylalanine ethyl ester hydrochloride (J1) L-p-Fluorophenylalanine (217 mg, 1.18 mmol) was dissolved in EtOH (5 ml) previously bubbled with HCl. The reaction was brought to 100° C. and was allowed to reflux for 18 hours. The solvent was evaporated off and the product was dried under high vacuum, affording L-p-fluorophenylalanine ethyl ester hydrochloride as dry white crystals (98percent). 1H NMR: (CD3OD) δ 7.30-7.26 (m, 2H, Ph-H), 7.13-7.06 (m, 2H, Ph-H), 4.29-4.22 (m, 2H, CH2-Ph), 3.31-3.10 (m, 3H, CH2CH3, α-H), 1.24 (t, 3H, CH2CH3). |
[ 64282-12-8 ]
Methyl 2-amino-3-(4-fluorophenyl)propanoate hydrochloride
Similarity: 0.97
[ 18125-46-7 ]
(R)-2-Amino-3-(4-fluorophenyl)propanoic acid
Similarity: 0.85
[ 1132-68-9 ]
(S)-2-Amino-3-(4-fluorophenyl)propanoic acid
Similarity: 0.85